Prenatal exposure to antinausea drug associated with increased colorectal cancer risk

In utero exposure to dicyclomine may be associated with increased risk for adult-onset colorectal cancer, results of a retrospective study suggest.Dicyclomine, an anticholinergic used to treat irritable bowel syndrome, was part of the original three-drug formulation for Bendectin (doxylamine, pyridoxine and dicyclomine) — an antinausea medication prescribed to pregnant women during the

Related Keywords

California ,United States ,Oakland ,Caitlinc Murphy , ,Kaiser Foundation Health Plan ,Child Health ,Uthealth Houston School Of Public Health ,Houston School ,Public Health ,Development Studies ,Kaiser Foundation Health ,California Cancer ,